The future of rectal cancer: Let's do the right trials

Journal of Clinical Oncology

Volumn 29, Issue 30, 2011, Pages 4057-4059

  Glynne Jones, Rob ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CETUXIMAB; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADD ON THERAPY; ADJUVANT THERAPY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; COLON CANCER; CONTINUOUS INFUSION; FUTUROLOGY; HUMAN; LETTER; LYMPH NODE METASTASIS; MULTICENTER STUDY (TOPIC); MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PELVIS LYMPHADENECTOMY; PHASE 2 CLINICAL TRIAL (TOPIC); PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM CANCER; RECTUM RESECTION; TREATMENT RESPONSE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HUMANS; RECTAL NEOPLASMS;

EID: 80054747522     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.37.1609     Document Type: Letter

References (24)

1. Mohiuddin M, Mohiuddin MM: Neoadjuvant chemoradiation in rectal cancer: Time to start in a new direction. J Clin Oncol 29:e350-e351, 2011
2. Gerard JP: Reply to M. Mohiuddin et al. J Clin Oncol 29:e352-e353, 2011
3. Gérard JP, Azria D, Gourgou-Bourgade S, et al.: Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: Results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol 28:1638-1644, 2010
4. Aschele C, Pinto C, Cordio S, et al.: Preoperative fluorouracil (FU)-based chemoradiation with and without weekly oxaliplatin in locally advanced rectal cancer: Pathologic response analysis of the Studio Terapia Adjuvante Retto (STAR)-01 randomized phase III trial. J Clin Oncol 27:804s, 2009 (suppl; abstr CRA4008)
5. Sauer R, Becker H, Hohenberger W, et al.: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731-1740, 2004
6. Bosset JF, Collette L, Calais G, et al.: Chemoradiotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114-1123, 2006 (Pubitemid 44394918)
7. Gérard JP, Conroy T, Bonnetain F, et al.: Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203. J Clin Oncol 24:4620-4625, 2006 (Pubitemid 46630960)
8. Roh MS, Colangelo LH, O'Connell MJ, et al.: Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP-R03. J Clin Oncol 27:5124-5130, 2009
9. Sebag-Montefiore D, Stephens RJ, Steele R, et al.: Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): A multicentre, randomised trial. Lancet 373:811-820, 2009
10. Quirke P, Steele R, Monson J, et al.: Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: A prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 373:821-828, 2009
11. Merkel S, Mansmann U, Siassi M, et al.: The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis 16:298-304, 2001 (Pubitemid 32927002)
12. Hermanek P, Merkel S, Fietkau R, et al.: Regional lymph node metastasis and locoregional recurrence of rectal carcinoma in the era of TME [corrected] surgery: Implications for treatment decisions. Int J Colorectal Dis 25:359-368, 2010
13. Shirouzu K, Akagi Y, Fujita S, et al.: Clinical significance of the mesorectal extension of rectal cancer: A Japanese multi-institutional study. Ann Surg 253:704-710, 2011
14. Tepper JE, Wang AZ: Improving local control in rectal cancer: Radiation sensitizers or radiation dose? J Clin Oncol 28:1623-1624, 2010
15. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al.: Sphincter preservation following preoperative radiotherapy for rectal cancer: Report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 72:15-24, 2004 (Pubitemid 38952855)
16. Ngan S, Fisher R, Goldstein D, et al.: A randomized trial comparing local recurrence (LR) rates between short-course (SC) and long-course (LC) preoperative radiotherapy (RT) for clinical T3 rectal cancer: An Intergroup trial (TROG, AGITG, CSSANZ, RACS). J Clin Oncol 28:263s, 2010 (suppl; abstr 3509)
17. Sugihara K, Kobayashi H, Kato T, et al.: Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum 49:1663-1672, 2006 (Pubitemid 44800483)
18. Quasar Collaborative Group, Gray R, Barnwell J: Adjuvant chemotherapy versus observation in patients with colorectal cancer: A randomised study. Lancet 370:2020-2029, 2007
19. André T, Boni C, Navarro M, et al.: Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 27:3109-3116, 2009
20. Taylor FG, Quirke P, Heald RJ, et al.: Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: A prospective, multicenter, European study that recruited consecutive patients with rectal cancer. Ann Surg [Epub ahead of print on January 13, 2011]
21. Frasson M, Garcia-Granero E, Roda D, et al.: Preoperative chemoradiation may not always be needed for patients with T3 and T2N+ rectal cancer. Cancer 117:3118-3125, 2011
22. Lezoche G, Baldarelli M, Guerrieri M, et al.: A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapy. Surg Endosc 22:352-358, 2008
23. Bujko K, Richter P, Kołodziejczyk M, et al.: Preoperative radiotherapy and local excision of rectal cancer with immediate radical re-operation for poor responders. Radiother Oncol 92:195-201, 2009
24. Habr-Gama A, Perez RO, Nadalin W, et al.: Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: Long term results. Ann Surg 240:711-771, 2004